NewsDesk @bactiman63 Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland....

By NewsDesk  @bactiman63 Seqirus announced Friday that the U.S. Food and Drug Administration (FDA) has approved FLUCELVAX® QUADRIVALENT (Influenza Vaccine), the company’s cell-based quadrivalent influenza...

NewsDesk @bactiman63 Clinical-stage vaccine company, FluGen today announced the publication of results from its Phase 2 human challenge study of Bris2007 M2SR, the Company’s investigational, supra-seasonal,...

Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, announced Wednesday  the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the Company’s...

By NewsDesk  @bactiman63 Seqirus announced this week that the U.S. Food and Drug Administration (FDA) has approved FLUCELVAX® QUADRIVALENT (Influenza Vaccine), the company’s cell-based quadrivalent...

More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a national survey. The survey of 1,027...

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation. The investigational...

A global leader in influenza prevention, Seqirus presented today absolute efficacy data on the company’s cell-based quadrivalent influenza vaccine (QIVc) from a randomized controlled trial (RCT)...

A recent health survey reveals that only two-thirds of parents say they’ll vaccinate their children against the flu this year, raising concerns among pediatricians as the flu season begins, some...

By NewsDesk  @bactiman63 With flu season approaching, the American Medical Association (AMA) is urging everyone six months and older to get vaccinated against the flu. During the 2020-2021 flu season,...